NCT01010178
Completed
Phase 4
Combination of Approved Drug in COPD
Baqiyatallah Medical Sciences University1 site in 1 country64 target enrollmentFebruary 2008
ConditionsChronic Obstructive Pulmonary Disease
InterventionsMacrolid, Theophylline, Inhaler Corticosteroids
Overview
- Phase
- Phase 4
- Intervention
- Macrolid, Theophylline, Inhaler Corticosteroids
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- Baqiyatallah Medical Sciences University
- Enrollment
- 64
- Locations
- 1
- Primary Endpoint
- 15% increasing in forced expiratory volume in 1 second
- Status
- Completed
- Last Updated
- 16 years ago
Overview
Brief Summary
Critical combination of various approved drugs in management for patients suffering with COPD.
Investigators
Eligibility Criteria
Inclusion Criteria
- •current or past smoker COPD
Exclusion Criteria
- •history of significant occupational or other environmental exposures or a connective tissue disease
Arms & Interventions
Macrolid, Theophylline, Corticosteroids
Approved drug in this setting
Intervention: Macrolid, Theophylline, Inhaler Corticosteroids
Outcomes
Primary Outcomes
15% increasing in forced expiratory volume in 1 second
Time Frame: 6 months
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 1
Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)HypercholesterolemiaNCT00653913Organon and Co18
Completed
Phase 3
COMBINE (Acamprosate/Naltrexone)AlcoholismNCT00006206University of North Carolina, Chapel Hill1,375
Completed
Phase 1
Pharmacotherapy & CM for Opioid and Cocaine DependenceCocaine DependenceNCT00838981Yale University91
Completed
Not Applicable
Prioritising and Optimising Multi-medication in MultimorbidityChronic DiseaseNCT01171339Goethe University505
Withdrawn
Not Applicable
Protocol for a Multi-site Pilot Study of the OptiMed Clinical TrialPolypharmacyMultiple Chronic ConditionsNCT06688591HES-SO Valais-Wallis